🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study was to evaluate the efficacy of olezarsen as compa...
Status
Completed
Location
Diabetes/Lipid Management & Research Center
Start Date
2020-11-18
Trial ID
NCT04568434
The purpose of the study was to evaluate the effect of olezarsen on percent...
Status
Completed
Location
Clinical Trials Research
Start Date
2022-05-09
Trial ID
NCT05355402
The purpose of the study is to assess the bioequivalence of olezarsen betwe...
Status
Completed
Location
Medpace Clinical Pharmacology Unit
Start Date
2022-10-05
Trial ID
NCT05579860
Treatments Being Tested
The purpose of the study is to evaluate the effect of olezarsen on percent ...
Status
Completed
Location
Alabama Clinical Therapeutics, LLC Alabaster
Start Date
2022-11-21
Trial ID
NCT05610280
The purpose of this study is to evaluate the efficacy of olezarsen as compa...
Status
Completed
Location
Central Research Associates, Inc.
Start Date
2022-08-31
Trial ID
NCT05552326
The purpose of this study is to evaluate the safety and tolerability of ole...
Status
Active Not Recruiting
Location
LA Universal Research Center, Inc.
Start Date
2022-12-13
Trial ID
NCT05681351
Treatments Being Tested
The purpose of the study is to evaluate the efficacy of olezarsen as compar...
Status
Completed
Location
Accel Research Sites Network
Start Date
2021-10-25
Trial ID
NCT05079919
The purpose of the Expanded Access Program is to provide pre-approval acces...
Status
Approved For Marketing
Location
Expanded Access Site
Start Date
TBD
Trial ID
NCT06360237
Treatments Being Tested
The primary purpose of the study is to evaluate the efficacy of olezarsen a...
Status
Recruiting
Location
University of Alabama
Start Date
2026-07-31
Trial ID
NCT07727538
Treatments Being Tested
The purpose of the study is to evaluate the safety, tolerability, pharmacok...
Status
Active Not Recruiting
Location
Diabetes/Lipid Management & Research Center
Start Date
2022-02-25
Trial ID
NCT05185843
Treatments Being Tested